Flash Chesco Stock Alert

By

Don’t look now but shares of Fibrocell (FCSC: NYSE), the Exton-based company focused on developing treatments for rare and serious skin and connective tissue damage and diseases, are up 41-percent in the last 30 days.

7.2.2014 Fibrocell

Previous coverage of Fibrocell on Chesco Business Today here and here.

 

Tags: , ,

Connect With Your Community

Subscribe to stay informed!

"*" indicates required fields

Hidden
VT Yes
This field is for validation purposes and should be left unchanged.
Advertisement
Creative Capital logo

You Might Also Like

Rite AidPharma & Biotech

WSJ: Rite Aid Strikes Deal To Transfer Control Over To Creditors, Settle Opioid Claims

Katalin Karikó in her lab in 1989.Pharma & Biotech

Abington's Katalin Karikó's New Book Shares Her Journey from Rejection to COVID-19 Vaccine Hero

Endo headquarters.Pharma & Biotech

Endo International in Malvern to Pay $465M in Opioid Settlement

Researcher working with microplate panel for diseases diagnosis in the laboratory. Doctor working with microplatePharma & Biotech

Malvern-Based Venatorx Pharmaceuticals Expects Big News About Its Lead Antibiotic Candidate